Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome is a rare, syndromic intellectual disability primarily characterized by moderate to severe intellectual disability, true-to-relative microcephaly and brain abnormalities including a thin corpus callosum, cerebellar hypoplasia, cerebral white matter hypoplasia and multi-focal hyperintensity of cerebral white matter on MRI. Obesity and distinctive craniofacial dysmorphism (including brachycephaly, round face, straight eyebrows, synophrys, hypertelorism, epicanthus, wide and depressed nasal bridge, protruding ears with uplifted lobe, downslanting corners of the mouth) are additional features.
Biomarker and diagnostic research for intellectual disability-obesity-brain malformations-facial dysmorphism syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for intellectual disability-obesity-brain malformations-facial dysmorphism syndrome.
202 publications have been identified in PubMed for intellectual disability-obesity-brain malformations-facial dysmorphism syndrome. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (25%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 55 | 33% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:11 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
42 |
25% |
Laboratory research | 41 | 25% |
Disease patterns and progression | 18 | 11% |
Testing and diagnosis research | 5 | 3% |
New treatment approaches | 3 | 2% |
Clinical study results | 2 | 1% |
Other research | 1 | 1% |
Andrade C (2026). [PMID: 41499180](https://pubmed.ncbi.nlm.nih.gov/41499180/). *J Clin Psychiatry*. [Review / Meta-Analysis]
Musante I (2026). [PMID: 41325909](https://pubmed.ncbi.nlm.nih.gov/41325909/). *Neurobiol Dis*. [Basic Science / Preclinical]
Tripathi M (2026). [PMID: 36256770](https://pubmed.ncbi.nlm.nih.gov/36256770/). *Unknown Journal*. [Case Report / Case Series]
Manav Yiğit Z (2026). [PMID: 41320952](https://pubmed.ncbi.nlm.nih.gov/41320952/). *Balkan Med J*. [Basic Science / Preclinical]
Rotulo GA (2026). [PMID: 41390316](https://pubmed.ncbi.nlm.nih.gov/41390316/). *Pediatr Neonatol*. [Review / Meta-Analysis]
Hindermann M (2026). [PMID: 41729076](https://pubmed.ncbi.nlm.nih.gov/41729076/). *JCI Insight*. [Basic Science / Preclinical]
Serpieri V (2026). [PMID: 41720098](https://pubmed.ncbi.nlm.nih.gov/41720098/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Costa SD (2026). [PMID: 40566944](https://pubmed.ncbi.nlm.nih.gov/40566944/). *J Child Neurol*. [Case Report / Case Series]
Guillon E (2026). [PMID: 41037499](https://pubmed.ncbi.nlm.nih.gov/41037499/). *Obes Facts*. [Review / Meta-Analysis]
Yeter B (2025). [PMID: 40742416](https://pubmed.ncbi.nlm.nih.gov/40742416/). *Eur J Pediatr*. [Case Report / Case Series]